Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
KING PHARMACEUTICALS Add to My Watchlist (NYSE: KG) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     KING 11.44 +0.14 (+1.24%) 3,200,013
501 Fifth Street
Bristol, TN 37620 US
(423) 989-8000
(423) 989-8711 fax
www.kingpharm.com
CEO Brian A. Markison
Auditor PRICEWATERHOUSECOOPERS LLP
Exchange Traded NY
ISIN Number US4955821081
CIK Number 1047699
NAICS Code 325412
Business Summary
A pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and and animal health products.
Number of Employees 3,381
Share Fundamentals
Market Cap 2.84B
Shares Outstanding 248.24M
Float 246.35M
Short Interest 8.57M
Financial Strength
Revenue (TTM) $1,685,126,000
Earnings (TTM) -$478,766,000
Quick Ratio 1.5:1
Current Ratio 2.2:1
Total Debt/Equity 0.27:1
Profitability
Gross Margin 64.1%
EBITDA Margin 27.7%
Profit Margin -24.3%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs